4-fluorodeprenyl has been researched along with mofegiline in 1 studies
| Studies (4-fluorodeprenyl) | Trials (4-fluorodeprenyl) | Recent Studies (post-2010) (4-fluorodeprenyl) | Studies (mofegiline) | Trials (mofegiline) | Recent Studies (post-2010) (mofegiline) |
|---|---|---|---|---|---|
| 10 | 0 | 2 | 38 | 9 | 2 |
| Protein | Taxonomy | 4-fluorodeprenyl (IC50) | mofegiline (IC50) |
|---|---|---|---|
| Membrane primary amine oxidase | Mus musculus (house mouse) | 0.01 | |
| Retina-specific copper amine oxidase | Homo sapiens (human) | 0.01 | |
| Amine oxidase [flavin-containing] B | Rattus norvegicus (Norway rat) | 0.0036 | |
| Amine oxidase [flavin-containing] A | Homo sapiens (human) | 1.265 | |
| Amine oxidase [flavin-containing] B | Homo sapiens (human) | 0.006 | |
| Membrane primary amine oxidase | Homo sapiens (human) | 0.02 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Heikkila, RE; Terleckyj, IA | 1 |
1 other study(ies) available for 4-fluorodeprenyl and mofegiline
| Article | Year |
|---|---|
In vivo and in vitro pharmacologic profile of two new irreversible MAO-B inhibitors: MDL 72,974A and fluorodeprenyl.
Topics: Allyl Compounds; Animals; Brain; Butylamines; Isoenzymes; Mice; Monoamine Oxidase Inhibitors; Rats; Selegiline | 1992 |